Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.270
-0.034 (-2.61%)
May 4, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 502.01 million as of May 4, 2026. Its market cap has increased by 17.00% in one year.
Market Cap
502.01M
Enterprise Value
568.99M
Revenue
71.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.27
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 502.01M, a decrease of -69.93%. That is a compound annual growth rate of -12.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 515.45M | -60.66% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.03B |
| SynAct Pharma AB | 984.51M |
| Cantargia AB | 896.00M |
| Infant Bacterial Therapeutics AB | 726.11M |
| FluoGuide | 668.69M |
| Corline Biomedical AB | 411.10M |
| Ascelia Pharma AB | 400.61M |
| Intervacc AB | 389.21M |